← Back to Search

Standing Desk Intervention for Sedentary Lifestyle

N/A
Recruiting
Led By Myles W O'Brien, PhD
Research Sponsored by Olga Theou
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline (week 0) activity to post intervention (week 4).
Awards & highlights

Study Summary

This trial will study effects of a standing desk converter on physical activity, posture, brain, heart & habitual activity patterns.

Who is the study for?
This trial is for adults over 18 who sit at a desk for more than 20 hours per week and don't already use a standing desk. They must be able to stand unassisted for at least 10 minutes, not be pregnant or planning pregnancy, have normal blood pressure and cognitive health, and no allergies to certain medical adhesives.Check my eligibility
What is being tested?
Researchers are testing if using a standing desk converter can increase physical activity levels, improve brain function (cognition), and regulate blood pressure better than usual seated work habits. Participants will either get the converter or continue their regular routine for comparison.See study design
What are the potential side effects?
There may not be direct side effects from using the standing desk converter; however, some individuals might experience discomfort or fatigue due to increased standing time compared to their usual seated work.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline (week 0) activity to post intervention (week 4).
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline (week 0) activity to post intervention (week 4). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ActivPAL monitors
Secondary outcome measures
Brain Activation: Functional Near Infrared Spectroscopy
Carotid Artery Function
Carotid Artery Structure
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Fitted with inclinometers/accelerometers at week 0 and week 4 of the intervention period for 7 consecutive days of wear. Measures of cognition and blood pressure regulation will occur at these same timepoints.
Group II: Wait-list Control GroupActive Control1 Intervention
Fitted with inclinometers/accelerometers at week 0 and week 4 of the intervention period for 7 consecutive days of wear. Measures of cognition and blood pressure regulation will occur at these same timepoints. Daily activities of participants will not be restricted if patients are assigned to the control group.

Find a Location

Who is running the clinical trial?

Olga TheouLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Sedentary Lifestyle
50 Patients Enrolled for Sedentary Lifestyle
Myles W O'Brien, PhDPrincipal InvestigatorDepartment of Medicine and Department of Physiotherapy, Dalhousie University

Media Library

Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05970588 — N/A
Sedentary Lifestyle Research Study Groups: Intervention Group, Wait-list Control Group
Sedentary Lifestyle Clinical Trial 2023: Intervention Group Highlights & Side Effects. Trial Name: NCT05970588 — N/A
Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05970588 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still seats available for participants in this experimental trial?

"The details hosted on clinicaltrials.gov point to the fact that this trial is no longer actively seeking candidates; it went live on September 1st 2023 and was last modified July 24th of the same year. Nevertheless, 32 other trials are now recruiting patients."

Answered by AI
~18 spots leftby Sep 2024